Latest Director Participation News

MEC Resources Ltd has announced a placement of over 359 million new options to raise approximately $359,000, with directors participating to offset fees. The offer comes as the company navigates ongoing legal challenges related to its key PEP-11 permit.

PTR Minerals has successfully raised $12 million through a share placement to accelerate development and exploration at its Rosewood Titanium and Muckanippie Heavy Mineral projects in South Australia.

Maggie Beer Holdings Ltd has announced a 1-for-10 non-renounceable entitlement offer priced at $0.056 per share, aiming to raise approximately $2.28 million to bolster its balance sheet and working capital. Eligible shareholders in Australia and New Zealand can participate, with options to apply for additional shares and a potential shortfall placement.

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.

Alvo Minerals has raised $2.26 million through a placement to accelerate drilling and exploration at its Palma Copper-Zinc Project in Brazil, including the promising new Touro Prospect.

Riedel Resources Limited has announced a 1 for 2 non-renounceable entitlement offer at $0.025 per share, aiming to raise approximately $1.78 million to fund exploration and working capital. The offer closes on 15 December 2025 and is open to eligible shareholders.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.

Krakatoa Resources has launched an offer of over 237 million new options linked to its recent $3.1 million placement, aiming to reward investors and advisors while providing potential future capital. The options are exercisable at $0.02 each before September 2028, with no immediate funds raised from the issue.

Critica Limited has raised A$8 million in an oversubscribed placement to accelerate development of its Jupiter rare earths project, positioning itself as a key supplier of critical minerals for emerging technologies.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Volt Group Limited has locked in a conditional $4 million placement to support its acquisition of 4D Delta, backed by strong institutional and director participation. The raise, priced at a discount to recent trading, aims to accelerate growth initiatives and strengthen working capital.

Catapult Sports has successfully closed its Share Purchase Plan, raising A$13.3 million as part of a broader A$143.3 million equity raising to support strategic expansion and acquisitions.